P-54 Circulating immune cells as a tool to predict benefit from atezolizumab/bevacizumab in advanced hepatocellular carcinoma (aHCC)
Titel:
P-54 Circulating immune cells as a tool to predict benefit from atezolizumab/bevacizumab in advanced hepatocellular carcinoma (aHCC)
Auteur:
Salani, F. Guerri, V. Cesario, S. Sammuri, P. Genovesi, V. Pratesi, F. Massa, V. Catanese, S. Vivaldi, C. Fornaro, L. Crea, F. Migliorini, P. Galimberti, S. Masi, G.